Rigel Pharmaceuticals Inc (RIGL)
CapEx to Revenue
0.00%
Quarterly · Period ending:
RIGL CapEx to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
RIGL Quarterly CapEx/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
RIGL capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0.0451% | |
| 0.0181% | |
| 0.6026% | |
| 0.4673% | |
| 0% | |
| 0% | |
| 0% | |
| 57.5374% | |
| 0.1424% | |
| 0.8434% | |
| 0.1207% | |
| 1.3385% | |
| 0.1029% | |
| 0.7891% | |
| 1.5495% | |
| 0.0876% | |
| 2.7317% | |
| 1.0604% | |
| 0.2746% | |
| 1.0886% | |
| 3.9675% | |
| 1.6877% | |
| 1.105% | |
| 2.9864% | |
| 0.1823% | |
| 3.2066% | |
| 38.2764% | |
| 0% | |
| 0% | |
| 6.2222% | |
| 0% | |
| 1.144% | |
| 0.2% | |
| 6.7021% | |
| 2.6181% | |
| 6.383% | |
| 1.5696% | |
| 2.3623% | |
| 1.4082% | |
| 1.4692% | |
| 1.8667% | |
| 0% | |
| 0% | |
| 0% | |
| 2.9217% | |
| 0% | |
| 17.7857% | |
| 0% | |
| 0% | |
| 0% | |
| 54.5333% | |
| 209.8667% | |
| 0% | |
| 12.8817% | |
| 176.4557% | |
| 0% | |
| -0.7424% | |
| 1.241% | |
| 2.6184% | |
| 13.4928% | |
| 6.1333% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0.8625% | |
| 0% | |
| 9.7137% | |
| 17.2088% | |
| 6.9693% | |
| 1.7953% | |
| 1.613% | |
| 3.5768% | |
| 20.9468% | |
| 0.6399% | |
| 1.65% | |
| 18.2582% | |
| 62.9091% | |
| 89.9848% | |
| 13.5844% | |
| 3.9005% | |
| 9.6391% | |
| 2.6153% | |
| 18.2205% | |
| 12.3638% | |
| 169.1892% | |
| 119.3266% | |
| 41.9875% | |
| 41.8497% | |
| 12.6805% | |
| 15.9296% |